Human M6PR/CD-M6PR/CD-MPR ORF/cDNA clone-Lentivirus plasmid (NM_002355)
Cat. No.: pGMLP000738
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human M6PR/CD-M6PR/CD-MPR Lentiviral expression plasmid for M6PR lentivirus packaging, M6PR lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
M6PR/CD-M6PR products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMLP000738 |
Gene Name | M6PR |
Accession Number | NM_002355 |
Gene ID | 4074 |
Species | Human |
Product Type | Lentivirus plasmid (overexpression) |
Insert Length | 834 bp |
Gene Alias | CD-M6PR,CD-MPR,MPR 46,MPR-46,MPR46,SMPR |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGTTCCCTTTCTACAGCTGCTGGAGGACTGGACTGCTACTACTACTCCTGGCTGTGGCAGTGAGAGAATCCTGGCAGACAGAAGAAAAAACTTGCGACTTGGTAGGAGAAAAGGGTAAAGAGTCAGAGAAAGAGTTGGCTCTAGTGAAGAGGCTGAAACCACTGTTTAATAAAAGCTTTGAGAGCACTGTGGGCCAGGGTTCAGACACATACATCTACATCTTCAGGGTGTGCCGGGAAGCTGGCAACCACACTTCTGGGGCAGGCCTGGTGCAAATCAACAAAAGTAATGGGAAGGAGACAGTGGTAGGGAGACTCAACGAGACTCACATCTTCAACGGAAGTAATTGGATCATGCTGATCTATAAAGGGGGTGATGAATATGACAACCACTGTGGCAAGGAGCAGCGTCGTGCAGTGGTGATGATCTCCTGCAATCGACACACCCTAGCGGACAATTTTAACCCTGTGTCTGAGGAGCGTGGCAAAGTCCAAGATTGTTTCTACCTCTTTGAGATGGATAGCAGCCTGGCCTGTTCACCAGAGATCTCCCACCTCAGTGTGGGTTCCATCTTACTTGTCACGTTTGCATCACTGGTTGCTGTTTATGTTGTTGGGGGGTTCCTATACCAGCGACTGGTAGTGGGAGCCAAAGGAATGGAGCAGTTTCCCCACTTAGCCTTCTGGCAGGATCTTGGCAACCTGGTAGCAGATGGCTGTGACTTTGTCTGCCGTTCTAAACCTCGAAATGTGCCTGCAGCATATCGTGGTGTGGGGGATGACCAGCTGGGGGAGGAGTCAGAAGAAAGGGATGACCATTTATTACCAATGTAG |
ORF Protein Sequence | MFPFYSCWRTGLLLLLLAVAVRESWQTEEKTCDLVGEKGKESEKELALVKRLKPLFNKSFESTVGQGSDTYIYIFRVCREAGNHTSGAGLVQINKSNGKETVVGRLNETHIFNGSNWIMLIYKGGDEYDNHCGKEQRRAVVMISCNRHTLADNFNPVSEERGKVQDCFYLFEMDSSLACSPEISHLSVGSILLVTFASLVAVYVVGGFLYQRLVVGAKGMEQFPHLAFWQDLGNLVADGCDFVCRSKPRNVPAAYRGVGDDQLGEESEERDDHLLPM |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-T97174-Ab | Anti-MPRD/ M6PR/ CD-M6PR monoclonal antibody |
Target Antigen | GM-Tg-g-T97174-Ag | M6PR VLP (virus-like particle) |
ORF Viral Vector | pGMLP000738 | Human M6PR Lentivirus plasmid |
ORF Viral Vector | vGMLP000738 | Human M6PR Lentivirus particle |
Target information
Target ID | GM-T97174 |
Target Name | M6PR |
Gene Group Identifier (Target Gene ID in Homo species) |
4074 |
Gene ID |
100061559 (Equus caballus), 101098389 (Felis catus), 17113 (Mus musculus), 281291 (Bos taurus) 312689 (Rattus norvegicus), 4074 (Homo sapiens), 477700 (Canis lupus familiaris), 716696 (Macaca mulatta) |
Gene Symbols & Synonyms | M6PR,M6pr,Mpr46,CD-MPR,CDMPR,SMPR,MPR46,MPR 46,MPR-46,CD-M6PR |
Target Alternative Names | M6PR,Cation-dependent mannose-6-phosphate receptor,CD Man-6-P receptor, CD-MPR,46 kDa mannose 6-phosphate receptor (MPR 46),SMPR,MPR46,CD-MPR,MPR 46,MPR-46,CD-M6PR |
Uniprot Accession |
P11456,P20645,P24668,Q6AY20
Additional SwissProt Accessions: P24668,P11456,Q6AY20,P20645 |
Uniprot Entry Name | |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target |
Disease | cancer |
Disease from KEGG | Lysosome, Phagosome |
Gene Ensembl | ENSECAG00000021995, ENSMUSG00000007458, ENSBTAG00000018207, ENSG00000003056, ENSCAFG00845028694, ENSMMUG00000017846 |
Target Classification | Tumor-associated antigen (TAA) |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.